SanDisk Joins Nasdaq-100, Replacing Atlassian on April 20 
FedEx Pilots and Union Reach Tentative Agreement on 40% Pay Increase 
U.S. Automakers Push Back Against EU Rules Blocking American Trucks from European Market 
Goldman Sachs, ANZ Cut Oil Forecasts Amid U.S.-Iran Ceasefire Hopes 
TSMC Posts Strong Q1 2025 Revenue, Riding AI Chip Demand Wave 
Anthropic's Mythos AI Model Sparks Emergency Cybersecurity Meeting With Top U.S. Bank CEOs 
Chalco Stock Surges as Q1 2025 Profit Forecast Jumps Up to 58% 
Chinese Cars in Europe: Consumer Trust Is Shifting Fast 
OpenAI Addresses Security Vulnerability in macOS App Certification Process 
China Vanke Seeks Bond Extension Amid Mounting Debt Crisis 
Kia Cuts EV Sales Target for 2030 Amid Slowing Demand and U.S. Policy Shifts 
Alibaba Shares Slide as Jefferies Slashes Price Target Over AI Spending and Business Losses 
Tokyo Electric Power Attracts Major Investors Amid Billion-Dollar Restructuring Push 
China's AI Stocks Surge as Zhipu and MiniMax Hit Record Highs 
Rio Tinto's California Boron Assets Attract Over a Dozen Bidders, Valued at Up to $2 Billion 
Foreign Investors Pour $18.65 Billion into Japanese Stocks Amid Market Stabilization 
MATCH Act: How New U.S. Chip Legislation Could Freeze China's Semiconductor Ambitions 
Illumina, Inc., a San Diego, California-headquartered biotechnology firm, announced that its chief financial officer, Joydeep Goswani, is leaving. His departure was confirmed on Tuesday, April 9.
New Executives at the HQ
The company said it has appointed Ankur Dhingra as its new CFO. Goswani's successor is revealed to be an executive at Summit Therapeutics. He will be leaving the company, where he most recently served in the same chief financial role, to join Illumina.
Aside from Dhingra, Illumina is also welcoming Jakob Wedel, who has been named the new chief strategy and corporate development officer. At any rate, Reuters reported that the new CFO worked at CareDx, a medical test manufacturer, before being hired at Summit Therapeutics. He also spent almost 18 years at Agilent Technologies and has decades of experience in the life science business sector.
Relocation and Date of Leadership Appointments
Meanwhile, Illumina's newly appointed senior executives, Dhingra and Wedel, are set to be transferred to San Diego for their respective roles. The two will start working at the company on April 15. On the other hand, Goswami will remain in the company until June 30 and officially leave on July 1.
"I am proud of the talent joining our management team as we work to deliver on Illumina's mission to improve human health by unlocking the power of the genome," Illumina's chief executive officer, Jacob Thaysen, said in a press release. "Ankur brings deep financial expertise, investor and leadership experience, and industry knowledge to Illumina's CFO role, and Jakob has keen insights gained from 25 years in strategy leadership roles with global consulting firms."
The CEO added, "We are grateful to Joydeep for his many contributions to Illumina over more than four years, and for most recently leading these two key functions. Joydeep will continue with us for several weeks to support a smooth leadership transition."
Photo by: Illumina Press Release
